*Private Practice* Staten Island — Staten Island, New York

*Private Practice* Staten Island is a clinical research site located in Staten Island, New York, United States.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

*Private Practice* Staten Island has participated in 1 clinical trials.

Therapeutic areas: Type 2 Diabetes Mellitus.

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for *Private Practice* Staten Island?

*Private Practice* Staten Island has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has *Private Practice* Staten Island conducted?

*Private Practice* Staten Island has 1 clinical trials on record. Their work covers Type 2 Diabetes Mellitus.

Is *Private Practice* Staten Island accredited by Crixeo Health?

*Private Practice* Staten Island has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about *Private Practice* Staten Island?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.